Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from MorningStar referenced a study published online ahead of print in the November 2024 issue of The American Journal of Managed Care®. The study, “Prescription Rebate Guarantees: Employer Insights,” focused on the role of employer benefits consultants and brokers in the selection of pharmacy benefit managers, as they may help in continuing the reliance on drug rebates, which are linked to higher list prices and higher out-of-pocket costs. Mark Cuban, owner of the Mark Cuban Cost Plus Drug Company, which buys and sells drugs at affordable prices, also shared the article on X.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More